Patient Derived Xenograft PDX Models Market

Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. PDX models are used to create an environment that allows for the natural growth of cancer, its monitoring, and corresponding treatment evaluations for the original patient.
Patient Derived Xenograft PDX Models Market aims to provide a comprehensive presentation of the global market for Patient Derived Xenograft & PDX Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Patient Derived Xenograft & PDX Models. Patient Derived Xenograft PDX Models Market contains market size and forecasts of Patient Derived Xenograft & PDX Models in global, including the following market information:
Global Patient Derived Xenograft & PDX Models Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Patient Derived Xenograft & PDX Models market was valued at US$ 341.2 million in 2022 and is projected to reach US$ 589.9 million by 2029, at a CAGR of 8.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global top 5 manufacturers of patient-derived xenograft (PDX) models occupied for a share nearly 45 percent, key players are Crown Bioscience, Champions Oncology, Wuxi Apptec, EPO Berlin-Buch, and Oncodesign, etc. Geographically speaking, Asia Pacific holds the most of global market share, about 35%. North America holds about 30% of share, while Europe followed by nearly 20%. In terms of type, mouse model accounted for nearly 75%, and rat model accounted for a share of 25%,The application of patient-derived xenograft (PDX) models includes preclinical drug development and biomarker analysis. Preclinical drug development shares over 75%, while biomarker analysis shares about 20%.
We surveyed the Patient Derived Xenograft & PDX Models companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Patient Derived Xenograft & PDX Models Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Patient Derived Xenograft & PDX Models Market Segment Percentages, by Type, 2022 (%)
Mice Models
Rat Models
Global Patient Derived Xenograft & PDX Models Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Patient Derived Xenograft & PDX Models Market Segment Percentages, by Application, 2022 (%)
Pre-clinical Drug Development and Basic Cancer Research
Biomarker Analysis
Global Patient Derived Xenograft & PDX Models Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Patient Derived Xenograft & PDX Models Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Patient Derived Xenograft & PDX Models revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Patient Derived Xenograft & PDX Models revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Crown Bioscience
The Jackson Laboratory
Champions Oncology
Charles River Laboratories
WuXi Apptec
Oncodesign
Horizon Discovery
Pharmatest Services
Hera Biolabs
EPO Berlin-Buch
Xentech
Urolead
Outline of Major Chapters:
Chapter 1: Introduces the definition of Patient Derived Xenograft & PDX Models, market overview.
Chapter 2: Global Patient Derived Xenograft & PDX Models market size in revenue.
Chapter 3: Detailed analysis of Patient Derived Xenograft & PDX Models company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Patient Derived Xenograft & PDX Models in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.